Please provide your email address to receive an email when new articles are posted on . Smilow Cancer Hospital has introduced a new single-port robotic prostatectomy procedure that reduces the number ...

Single‐port robotic surgery represents a significant advance in minimally invasive urology. This technique employs a dedicated robotic platform through a single incision, thereby reducing surgical ...

DETROIT - The Vattikuti Urology Institute at Henry Ford Hospital is the first center in the country to routinely perform surgery using a robotic system for the treatment of prostate cancer. With this ...

PHILADELPHIA, PA - Prostate cancer is the second leading cause of death among American men. It is estimated that one in six males will develop the disease during his lifetime. However, promising new ...

Prostate cancer ranks as the most prevalent form of cancer among men, following only skin cancer in diagnosis frequency. Upon receiving a diagnosis, comprehending the available treatment options ...

(TNS) — When Dr. Mitchell Sokoloff was training as a urologist in the early 1990s, he recalled that the advice for surgical incisions was “the bigger the better.” Fast forward to Tuesday, and his two ...

WORCESTER — When Dr. Mitchell Sokoloff was training as a urologist in the early 1990s, he recalled that the advice for surgical incisions was “the bigger the better.” Fast forward to Tuesday, and his ...

This content is sponsored by MedStar Washington Hospital Center. Prostate cancer is the most common cancer among men (after skin cancer), but it can often be treated successfully. It affects the ...

Prostate cancer is the most common cancer among men in the US, aside from skin cancer. About 13% of male Americans will get it — and treatment often comes with the risk of erectile dysfunction. Relief ...

The EAU 2026 CAPTAIN study presentation will be given by Laurence Klotz, CM, MD, FRCSC, an esteemed urologist, a professor of surgery at the University of Toronto, the Sunnybrook Chair of Prostate ...

At 24 months' follow-up, the only phase 3 randomized clinical trial to directly compare functional and oncologic outcomes between robot-assisted laparoscopic prostatectomy and open radical retropubic ...